Sebastian Zeissig
Overview
Explore the profile of Sebastian Zeissig including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
8729
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanchez Alvarez R, Montalban-Arques A, Morsy Y, Gottier C, Hafliger J, Atrott K, et al.
J Crohns Colitis
. 2025 Jan;
19(2).
PMID: 39873381
Background And Aims: Protein tyrosine phosphatase nonreceptor type 23 (PTPN23) regulates the internalization of growth factor receptors such as the epithelial growth factor receptor (EGFR). Given the crucial function of...
2.
Goel M, Steinberg-Bains K, Eugster A, Wehner R, Tunger A, Reinhardt S, et al.
Biochem Biophys Res Commun
. 2025 Jan;
749:151353.
PMID: 39837221
Gastrointestinal T cells (GI-T) play a critical role in mucosal immunity, balancing tolerance and pathogen defence. T cells recognize antigens via T cell receptors (TCRs). Next-generation sequencing (NGS) is utilized...
3.
Misselwitz B, Zeissig S, Schreiber S, Dignass A
Inn Med (Heidelb)
. 2025 Jan;
66(1):3-14.
PMID: 39747696
Background: The treatment options for chronic inflammatory bowel diseases (IBD) have been greatly expanded due to a better understanding of the underlying pathogenesis. A total of five classes of advanced...
4.
Husman J, Cerna K, Matthes K, Gilger M, Arsova M, Schmidt A, et al.
Int J Colorectal Dis
. 2024 Sep;
39(1):151.
PMID: 39317813
Purpose: Immunogenicity is a major reason for secondary loss of response to infliximab (IFX). Recent work suggested potentially lower immunogenicity of subcutaneous (SC) compared to intravenous (IV) IFX. However, it...
5.
Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignass A, Ehehalt R, et al.
Z Gastroenterol
. 2024 Aug;
62(8):1229-1318.
PMID: 39111333
No abstract available.
6.
Schmache T, Fohgrub J, Klimova A, Laaber K, Drukewitz S, Merboth F, et al.
Mol Cancer
. 2024 Jan;
23(1):10.
PMID: 38200602
Background And Aims: This study sought to determine the value of patient-derived organoids (PDOs) from esophago-gastric adenocarcinoma (EGC) for response prediction to neoadjuvant chemotherapy (neoCTx). Methods: Endoscopic biopsies of patients...
7.
Brinkmann F, Uhlig K, Sambale A, Stommel M, Berning M, Babatz J, et al.
Gastrointest Endosc
. 2023 Oct;
99(3):377-386.e3.
PMID: 37863243
Background And Aims: Stent migration and subsequent adverse events are frequently observed in the use of fully covered self-expandable metal stents (FCSEMSs) for distal biliary stenosis. In this study, we...
8.
Perakakis N, Harb H, Hale B, Varga Z, Steenblock C, Kanczkowski W, et al.
Lancet Diabetes Endocrinol
. 2023 Jul;
11(9):675-693.
PMID: 37524103
Viruses have been present during all evolutionary steps on earth and have had a major effect on human history. Viral infections are still among the leading causes of death. Another...
9.
Metwaly A, Jovic J, Waldschmitt N, Khaloian S, Heimes H, Hacker D, et al.
Microbiome
. 2023 Apr;
11(1):66.
PMID: 37004103
Background: Crohn's disease (CD) is associated with changes in the microbiota, and murine models of CD-like ileo-colonic inflammation depend on the presence of microbial triggers. Increased abundance of unknown Clostridiales...
10.
Geissler M, Zeissig S
Immunity
. 2022 Oct;
55(10):1758-1760.
PMID: 36223724
The spectrum and origin of commensal bacterial HLA epitopes is not well understood. In this issue of Immunity, Pedersen et al. provide a systematic analysis of commensal bacterial HLA II...